Product Pipeline

Pipeline

Oncothyreon is developing small molecules and therapeutic vaccines, increasing our opportunities to improve the lives and outcomes for cancer patients.
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >

Pipeline

Oncothyreon's pipeline of innovative product candidates includes small molecule compounds and immunotherapies that target diverse aspects of cancer. Developing candidates with distinct mechanisms of action enhances our ability to provide clinical benefit across multiple cancer indications.

 
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
 
Disc
Pre
P1
P2
P3
Clinical Programs
 
 
 
 
 
 
 
 
 
 
Breast
Ovarian
 
 
 
 
 
Adjuvant Technology
 
 
 
 
 
 
 
 
 
 
Research Programs
 
 
 
 
 
Oncology
Rare Diseases
 
 
 
 
 
Immunotherapy
(Antibody)
Oncology
 
 
 
 
 
Licensed from Array BioPharma
Licensed from Sentinel Oncology
Research Collaboration with Adimab LLC
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >